Table 1 Clinical and pathological characteristics of patients and tumor samples
Variables | N = 30 |
|---|---|
Age (years) | 62.5 (48.8-76.0) |
Clinicopathological parameters | |
Breast carcinoma type | |
Luminal-A (%) | 10 (33) |
Her-2 (%) | 10 (33) |
TN (%) | 10 (33) |
Histologic types | |
Invasive ductal carcinoma (%) | 26 (87) |
Medullary carcinoma (%) | 2 (7) |
Papillary carcinoma (%) | 1 (3) |
Mixed carcinoma (%) | 1 (3) |
Nottingham combined histologic grade | |
Grade I (%) | 6 (20) |
Grade II (%) | 4 (13) |
Grade III (%) | 20 (67) |
TNM staging | |
Stage IA (%) | 7 (23) |
Stage IIA (%) | 14 (47) |
Stage IIB (%) | 4 (13) |
Stage IIIA (%) | 2 (7) |
Stage IIIB (%) | 1 (3) |
Stage IV (%) | 1 (3) |
Unknown (%) | 1 (3) |
Tumor size (cm) | 3.00 (2.00-4.00) |
Lymph node affected (%) | 10 (33) |
Vascular invasion (%) | 4 (13) |
Tumor necrosis (%) | 12 (40) |
Mean Ki-67 (%) | 20 (5–53) |
Ki-67 over 20 (%) | 15 (50) |
Other conditions | |
Dyslipidemia (%) | 11 (38) |
Menopause (%) | 15 (50) |
Intratumor lipid parameters | |
CE (μg/mg protein) | 3.14 (1.45-4.65) |
TG (μg/mg protein) | 5.91 (2.87-13.95) |
Free Chl (μg/mg protein) | 4.97 (4.47-5.50) |